NMDA receptor deficits have been implicated in schizophrenia. Grent-’t-Jong et al. show that treating healthy controls with ketamine triggers changes in neural oscillations during visual processing distinct from those seen… Click to show full abstract
NMDA receptor deficits have been implicated in schizophrenia. Grent-’t-Jong et al. show that treating healthy controls with ketamine triggers changes in neural oscillations during visual processing distinct from those seen in patients with schizophrenia. This suggests that acute NMDA receptor hypofunction does not account for visuo-perceptual deficits in the disorder.
               
Click one of the above tabs to view related content.